Amethyst Tablet
Product Images NDC 0480-3472

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Amethyst (NDC 0480-3472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levonorgestrel (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 1)

Levonorgestrel (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 1)
Chemical structure of the active ingredient in Amethyst, Levonorgestrel and Ethinyl Estradiol, a human prescription drug oral tablet. The diagram shows the molecular arrangement of atoms and bonds characteristic of this combined hormonal contraceptive.*
FDA Label Image

Figure 4 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 10)

Figure 4 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 10)
A vertical bar chart depicting the percentage of women experiencing bleeding or spotting only over a 13-week period. The chart differentiates bleeding (solid black) and spotting only (crosshatched) occurrences, showing a general decline in total percentages from week 2 to week 13.*
FDA Label Image

Figure 5 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 11)

Figure 5 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 11)
A bar chart depicting the percentage of subjects experiencing bleeding days across different pill packs for Amethyst tablets. The x-axis represents pill packs numbered from -2 to 13, while the y-axis shows the percentage of subjects. Each bar is segmented to illustrate subjects with bleeding for 4 or more days (black section) and 7 or more days (white section).*
FDA Label Image

Blister (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 12)

Blister (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 12)
Amethyst brand oral contraceptive tablets by Teva Pharmaceuticals, containing Levonorgestrel and Ethinyl Estradiol 90 mcg/20 mcg. The image shows a blister card with 28 circular tablet compartments arranged in four rows, labeled with days of the week (Sun to Sat) to guide daily use. The label includes storage instructions and a reminder for monthly self-breast exams.*
FDA Label Image

Carton (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 13)

Carton (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 13)
Packaging label for Amethyst 90 mcg/20 mcg tablets. Each tablet contains 90 mcg levonorgestrel and 20 mcg ethinyl estradiol. The product is an oral tablet supplied in a 1 tablet dispenser with 28 tablets each. Labeler is Teva Pharmaceuticals, Inc. The label includes dosage information, storage conditions, and warnings about oral contraceptives.*
FDA Label Image

Ethinyl Estradiol (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 2)

Ethinyl Estradiol (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 2)
Chemical structure of Levonorgestrel, one of the active ingredients in the Amethyst oral tablet. The diagram displays the molecular arrangement including hydroxyl groups and specific carbon bonds relevant to the hormone's structure.*
FDA Label Image

Figure 1 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 3)

Figure 1 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 3)
Two line graphs showing plasma concentration profiles over time for Levonorgestrel (top) and Ethinyl Estradiol (bottom) after oral administration. Each graph displays mean plasma concentration (ng/mL for Levonorgestrel, pg/mL for Ethinyl Estradiol) on the y-axis and time in hours on the x-axis, with data points for Day 1, Day 14, and Day 28, including error bars to indicate variability.*
FDA Label Image

Figure 2 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 4)

Figure 2 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 4)
A bar graph titled with legend 'Amenorrhea' showing the percentage of subjects on the vertical axis and pill pack day numbers on the horizontal axis, ranging from 1–13 to 13–13. The bars represent increasing percentages of subjects experiencing amenorrhea across the days within the pill pack, with values rising from near 0% up to about 60% by day 13–13.*
FDA Label Image

Figure 3 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 5)

Figure 3 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 5)
A bar chart comparing four groups: ever-users (nonsmokers), ever-users (smokers), controls (nonsmokers), and controls (smokers) across age ranges 15-24, 25-34, 35-44, and 45+. The chart shows increasing bar heights with age, notably highest bars in the 45+ age group, particularly for ever-users (smokers).*
FDA Label Image

Figure 4 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 6)

Figure 4 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 6)
A stacked bar graph showing the percentage of women experiencing 'Bleeding' and 'Spotting Only' across different months, labeled from -2 to 13. The vertical axis represents the percentage of women, ranging from 0 to 100, with 'Bleeding' depicted in solid black and 'Spotting Only' in crosshatched pattern.*
FDA Label Image

Figure 5 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 7)

Figure 5 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 7)
A bar graph showing the percentage of subjects who used the drug for '7 or more days' (white bars) and '4 or more days' (black segments) across different pill packs numbered from 2 to 13. The vertical axis represents percentage of subjects, and the horizontal axis represents the pill pack number.*
FDA Label Image

Figure 6 (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 8)

Figure 6 (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 8)
A forest plot displaying effect estimates (odds ratios or relative risks) and 95% confidence intervals from multiple women’s contraceptive studies between 2002 and 2017. Each study is labeled by name and year, with effect estimates ranging approximately from 0.9 to 1.3 along the horizontal axis.*
FDA Label Image

Blister (Amethyst Levonorgestrel And Ethinyl Estradiol Ta 9)

Blister (Amethyst   Levonorgestrel And Ethinyl Estradiol Ta 9)
The image shows a blister pack of Amethyst tablets containing Levonorgestrel and Ethinyl Estradiol at a strength of 90 mcg/20 mcg. The pack is labeled for oral use and includes a 28-day calendar layout with days of the week indicated. The product is from Teva Pharmaceuticals, Inc. and is marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.